FDx Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

FDx Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,002	Closed	-$180K	–	1302
2017 Q4	$180K	Buy	+10,002	New	+$123K	﹤0.01%	1201
2017 Q3	–	Sell	-11,107	Closed	-$117K	–	1322
2017 Q2	$117K	Buy	+11,107	New	+$113K	﹤0.01%	1168

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

FDx Advisors's SCMP Position: Q1 2018 in Review

FDx Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 10,002 shares — an estimated $180K sold.

FDx Advisors first reported a position in SCMP in Q2 2017 and held it in 2 quarters. The position peaked at $180K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

FDx Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
FDx Advisors sold 10,002 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $180K.
FDx Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2017 and held it in 2 quarters.
FDx Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $180K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on FDx Advisors's 13F filing for Q1 2018, filed 2 May 2018.